Differential diagnosis of familial high density lipoprotein deficiency syndromes

The Metabolic and Molecular Bases of Inherited Disease

Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101 · see citing works

The metabolic and molecular bases of inherited disease

Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928 · see citing works

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687 · see citing works

Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol

Cohen, J. C., Kiss, R. S., Pertsemlidis, A., Marcel, Y. L., McPherson, R., & Hobbs, H. H. (2004) · Science · doi:10.1126/science.1099870 · Cited by 1,108 · see citing works

High Density Lipoproteins and Arteriosclerosis

von Eckardstein, A., Nofer, J., & Assmann, G. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.1.13 · Cited by 696 · see citing works

Familial lipoprotein disorders in patients with premature coronary artery disease.

Genest, J. J., Martin-Munley, S., McNamara, J. R., Ordovás, J. M., Jenner, J. L., Myers, R. H., Silberman, S. R., Wilson, P. W., Salem, D. N., & Schaefer, E. J. (1992) · Circulation · doi:10.1161/01.cir.85.6.2025 · Cited by 598 · see citing works

Lecithin cholesterol acyltransferase

Jonas, A. M. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00153-0 · Cited by 475 · see citing works

The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes

Kuivenhoven, J. A., Pritchard, H., Hill, J. S., Frohlich, J., Assmann, G., & Kastelein, J. J. P. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37433-2 · Cited by 364 · see citing works

Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes

Clee, S. M., Kastelein, J. J. P., van Dam, M., Marcil, M., Roomp, K., Zwarts, K. Y., Collins, J. A., Roelants, R. J., Tamasawa, N., Štulc, T., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10727 · Cited by 314 · see citing works

Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux

Wang, N., & Tall, A. R. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000075912.83860.26 · Cited by 259 · see citing works

Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population

Frikke‐Schmidt, R., Nordestgaard, B. G., Jensen, G. B., & Tybjærg‐Hansen, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20361 · Cited by 249 · see citing works

Efflux and Atherosclerosis

Singaraja, R. R., Brunham, L. R., Visscher, H., Kastelein, J. J. P., & Hayden, M. R. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000078520.89539.77 · Cited by 245 · see citing works

Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease

Gotto, A. M., & Brinton, E. A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.061 · Cited by 228 · see citing works

Lecithin: cholesterol acyltransferase deficiency and fish-eye disease

Assmann, G., von Eckardstein, A., & Funke, H. (1991) · Current Opinion in Lipidology · doi:10.1097/00041433-199104000-00009 · Cited by 191 · see citing works

The Effects of Altered Apolipoprotein A-I Structure on Plasma HDL Concentration

Sorci‐Thomas, M. G., & Thomas, M. J. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00163-3 · Cited by 189 · see citing works

The Molecular Basis of Lecithin:Cholesterol Acyltransferase Deficiency Syndromes

Calabresi, L., Pisciotta, L., Costantin, A., Frigerio, I., Eberini, I., Alessandrini, P., Arca, M., Bon, G. B., Boscutti, G., Busnach, G., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000175751.30616.13 · Cited by 171 · see citing works

Genetics of Variation in HDL Cholesterol in Humans and Mice

Wang, X., & Paigen, B. J. (2005) · Circulation Research · doi:10.1161/01.res.0000151332.39871.13 · Cited by 139 · see citing works

Impaired ABCA1-dependent Lipid Efflux and Hypoalphalipoproteinemia in Human Niemann-Pick type C Disease

Choi, H. Y., Karten, B., Chan, T., Vance, J. E., Greer, W. L., Heidenreich, R. A., Garver, W. S., & Francis, G. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304553200 · Cited by 138 · see citing works

Lipid abnormalities in children with types A and B Niemann Pick disease

McGovern, M. M., Pohl-Worgall, T., Deckelbaum, R. J., Simpson, W. L., Mendelson, D., Desnick, R. J., Schuchman, E. H., & Wasserstein, M. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.02.048 · Cited by 136 · see citing works

A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease

Hovingh, G. K., Brownlie, A., Bisoendial, R. J., Dubé, M., Levels, J. H. M., Petersen, W., Dullaart, R. P. F., Stroes, E. S. G., Zwinderman, A. H., de Groot, E., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.070 · Cited by 129 · see citing works

Study of ABCA1 function in transgenic mice.

Joyce, C. W., Freeman, L., Brewer, H., & Santamarina-Fojo, S. (2003) · Arteriosclerosis, Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000055194.85073.ff · Cited by 118 · see citing works

Inherited disorders of HDL metabolism and atherosclerosis

Hovingh, G. K., de Groot, E., van der Steeg, W. A., Boekholdt, S. M., Hutten, B. A., Kuivenhoven, J. A., & Kastelein, J. J. P. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000162318.47172.ef · Cited by 116 · see citing works

Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure.

von Eckardstein, A., Funke, H., Walter, M., Altland, K., Benninghoven, A., & Assmann, G. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38931-8 · Cited by 105 · see citing works

In-Depth Haplotype Analysis of ABCA1 Gene Polymorphisms in Relation to Plasma ApoA1 Levels and Myocardial Infarction

Trégouët, D., Ricard, S., Nicaud, V., Reguigne-Arnould, I., Soubigou, S., Rosier, M., Duverger, N., Poirier, O., Macé, S., Kee, F., et al. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000121573.29550.1a · Cited by 102 · see citing works

Haplotypes and SNPs in 13 lipid-relevant genes explain most of the genetic variance in high-density lipoprotein and low-density lipoprotein cholesterol

Knoblauch, H. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh119 · Cited by 101 · see citing works

Apolipoprotein A-IMilano: current perspectives

Chiesa, G., & Sirtori, C. R. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200304000-00007 · Cited by 101 · see citing works

Conformational Switching and Fibrillogenesis in the Amyloidogenic Fragment of Apolipoprotein A-I

Andreola, A., Bellotti, V., Giorgetti, S., Mangione, P. P., Obici, L. P., Stoppini, M., Torres, J., Monzani, E., Merlini, G., & Sunde, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m204801200 · Cited by 93 · see citing works

Familial analphalipoproteinemia : Tangier disease

Assmann, G. (2001) · Medical Entomology and Zoology · Cited by 92 · see citing works

High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Insights from mutations.

Assmann, G., von Eckardstein, A., & Funke, H. (1993) · PubMed · Cited by 91 · see citing works

Multicenter evaluation of a homogeneous assay for HDL-cholesterol without sample pretreatment

Nauck, M. A., März, W., Jarausch, J., Cobbaert, C. M., Sägers, A., Bernard, D., Delanghe, J., Honauer, G., Lehmann, P., Östrich, E., et al. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.9.1622 · Cited by 90 · see citing works

Lecithin: cholesterol acyltransferase (LCAT) deficiency and risk of vascular disease: 25 year follow-up

Ayyobi, A. F., McGladdery, S. H., Chan, S., Mancini, G. B. J., Hill, J. S., & Frohlich, J. J. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.07.018 · Cited by 83 · see citing works

Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families

Obici, L. P., Palladini, G. O., Giorgetti, S., Bellotti, V., Gregorini, G. A., Arbustini, E., Verga, L., Marciano, S., Donadei, S., Perfetti, V., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.003 · Cited by 82 · see citing works

High Density Lipoproteins in Health and in Disease

Genest, J. J., Marcil, M., Denis, M., & Yu, L. (1999) · Journal of Investigative Medicine · doi:10.1177/108155899904700106 · Cited by 80 · see citing works

Apolipoprotein A-I(Milano): current perspectives.

Chiesa, G., & Sirtori, C. R. (2003) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000064048.08840.b4 · Cited by 78 · see citing works

The replacement of arginine by cysteine at residue 151 in Apolipoprotein A-I produces a phenotype similar to that of Apolipoprotein A-I Milano

Bruckert, É., von Eckardstein, A., Funke, H., Beucler, I., Wiebusch, H., Turpin, G., & Assmann, G. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)05982-5 · Cited by 62 · see citing works

Compound Heterozygosity for a Structural Apolipoprotein A-I Variant, Apo A-I(L141R) Pisa , and an Apolipoprotein A-I Null Allele in Patients With Absence of HDL Cholesterol, Corneal Opacifications, and Coronary Heart Disease

Miccoli, R., Bertolotto, A., Navalesi, R., Odoguardi, L., Boni, A., Weßling, J., Funke, H., Wiebusch, H., von Eckardstein, A., & Assmann, G. (1996) · Circulation · doi:10.1161/01.cir.94.7.1622 · Cited by 59 · see citing works

Apoa1 related amyloidosis: a case report and literature review

JOY, T. R., Wang, J., Hahn, A. F., & Hegele, R. A. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(03)00110-3 · Cited by 54 · see citing works

β-glucocerebrosidase gene locus as a link for Gaucher's disease and familial hypo-α-lipoproteinaemia

Pocovı́, M., Cenarro, A., Civeira, F., Torralba, M. A., Pérez‐Calvo, J. I., Mozas, P., Giraldo, P., Giralt, M., Myers, R. H., Cupples, L. A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09490-7 · Cited by 52 · see citing works

Apolipoprotein A-I Zavalla (Leu 159 →Pro)

Miller, M. J., Aiello, D. P., Pritchard, H., Friel, G., & Zeller, K. I. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.8.1242 · Cited by 51 · see citing works

A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas.

Römling, R., von Eckardstein, A., Funke, H., Motti, C., Fragiacomo, G. C., Noseda, G., & Assmann, G. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.12.1915 · Cited by 50 · see citing works

Diagnosis of hereditary neuropathies in adult patients

Pareyson, D. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1030-3 · Cited by 48 · see citing works

The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia

Hovingh, G. K., van Wijland, M. J. A., Brownlie, A., Bisoendial, R. J., Hayden, M. R., Kastelein, J. J. P., & Groen, A. K. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300080-jlr200 · Cited by 45 · see citing works

Screening for functional sequence variations and mutations in ABCA1

Probst, M. C. O. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.02.019 · Cited by 45 · see citing works

A Novel in Vivo Lecithin-Cholesterol Acyltransferase (LCAT)-Deficient Mouse Expressing Predominantly LpX Is Associated with Spontaneous Glomerulopathy

Zhu, X., Herzenberg, A. M., Eskandarian, M. R., Maguire, G. F., Scholey, J. W., Connelly, P. W., & Ng, D. S. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63386-x · Cited by 44 · see citing works

Genotypic Effect of the −565C>T Polymorphism in the ABCA1 Gene Promoter on ABCA1 Expression and Severity of Atherosclerosis

Kyriakou, T., Hodgkinson, C. P., Pontefract, D. E., Iyengar, S., Howell, W. M., Wong, Y.-K., Eriksson, P. O., & Ye, S. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000149379.72018.20 · Cited by 43 · see citing works

Relative Contributions of Genes, Environment, and Interactions to Blood Lipid Concentrations in a General Adult Population

Costanza, M. C. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi103 · Cited by 43 · see citing works

A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease

Ikewaki, K., Matsunaga, A., Han, H., Watanabe, H., Endo, A., Tohyama, J., Kuno, M., Mogi, J., Sugimoto, K., Tada, N., et al. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.09.024 · Cited by 42 · see citing works

Structure and function of lecithin cholesterol acyl transferase: new insights from structural predictions and animal models

Peelman, F., Vandekerckhove, J. S., & Rosseneu, M. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200004000-00008 · Cited by 31 · see citing works

Familial high‐density‐lipoprotein deficiency causing corneal opacities (fish eye disease) in a family of Dutch descent

Kastelein, J. J. P., Pritchard, P. H., Erkelens, D. W., Kuivenhoven, J. A., Albers, J. J., & Frohlich, J. J. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00953.x · Cited by 22 · see citing works

A Review of the Treatment Guidelines on the Management of Low Levels of High-Density Lipoprotein Cholesterol

Devroey, D., Vantomme, K., Betz, W., Vandevoorde, J., & Kartounian, J. (2004) · Cardiology · doi:10.1159/000077906 · Cited by 15 · see citing works

Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients

von Eckardstein, A., Huang, Y., Kastelein, J. J. P., Geisel, J., Real, J. T., Kuivenhoven, J. A., Miccoli, R., Noseda, G., & Assmann, G. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00280-3 · Cited by 15 · see citing works

European guidelines on cardiovascular disease prevention in clinical practice: executive summary

Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,840 · see citing works

Untitled work

Graham (2007) · doi:10.1097/01.hjr.0000277983.23934.c9 · Cited by 1,647 · see citing works

European guidelines on cardiovascular disease prevention in clinical practice: Executive summary

Graham, I. M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.08.024 · Cited by 715 · see citing works

Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)

Graham, I. D., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000277984.31558.c4 · Cited by 286 · see citing works

HDL cholesterol: reappraisal of its clinical relevance

März, W., Kleber, M. E., Scharnagl, H., Speer, T., Zewinger, S., Ritsch, A., Parhofer, K. G., von Eckardstein, A., Landmesser, U., & Laufs, U. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-017-1106-1 · Cited by 275 · see citing works

Genetic causes of high and low serum HDL-cholesterol

Weissglas‐Volkov, D., & Pajukanta, P. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r004739 · Cited by 219 · see citing works

Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance?

Li, N., Fu, J., Koonen, D. P. Y., Kuivenhoven, J. A., Snieder, H., & Hofker, M. H. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.013 · Cited by 177 · see citing works

Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: A systematic in-depth review

Boes, E., Coassin, S., Kollerits, B., Heid, I. M., & Kronenberg, F. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.11.003 · Cited by 121 · see citing works

Three-dimensional models of HDL apoA-I: implications for its assembly and function

Thomas, M. J., Bhat, S., & Sorci‐Thomas, M. G. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800010-jlr200 · Cited by 107 · see citing works

Guía europea de prevención cardiovascular en la práctica clínica: Adaptación española del CEIPC 2008

Lobos, J., Royo-Bordonada, M. A., Brotons, C., Álvarez-Sala, L., Armario, P., Maiques, A., Mauricio, D., Sans, S., Villar, F., Lizcano, Á., et al. (2008) · Revista Española de Salud Pública · doi:10.1590/s1135-57272008000600002 · Cited by 94 · see citing works

Tangier Disease

Puntoni, M., Sbrana, F., Bigazzi, F., & Sampietro, T. (2012) · American Journal of Cardiovascular Drugs · doi:10.1007/bf03261839 · Cited by 95 · see citing works

Genetic Analysis of 103 Candidate Genes for Coronary Artery Disease and Associated Phenotypes in a Founder Population Reveals a New Association between Endothelin-1 and High-Density Lipoprotein Cholesterol

Paré, G., Serre, D., Brisson, D., Anand, S. S., Montpetit, A., Tremblay, G., Engert, J. C., Hudson, T. J., & Gaudet, D. (2007) · The American Journal of Human Genetics · doi:10.1086/513286 · Cited by 86 · see citing works

Approach to the Patient with Extremely Low HDL-Cholesterol

Rader, D. J., & deGoma, E. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2185 · Cited by 79 · see citing works

Activation of lecithin: cholesterol acyltransferase by HDL ApoA-I central helices

Sorci‐Thomas, M. G., Bhat, S., & Thomas, M. J. (2009) · Clinical Lipidology · doi:10.2217/17584299.4.1.113 · Cited by 75 · see citing works

Monogenic pediatric dyslipidemias: Classification, genetics and clinical spectrum

Rahalkar, A. R., & Hegele, R. A. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.10.007 · Cited by 74 · see citing works

Conformational Adaptation of Apolipoprotein A-I to Discretely Sized Phospholipid Complexes

Bhat, S., Sorci‐Thomas, M. G., Tuladhar, R., Samuel, M. P., & Thomas, M. J. (2007) · Biochemistry · doi:10.1021/bi700384t · Cited by 67 · see citing works

Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT

Tietjen, I., Hovingh, G. K., Singaraja, R., Radomski, C., McEwen, J., Chan, E., Mattice, M., Legendre, A., Kastelein, J. J. P., & Hayden, M. R. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.08.006 · Cited by 58 · see citing works

Human genetics of HDL: Insight into particle metabolism and function

Brunham, L. R., & Hayden, M. R. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.01.001 · Cited by 52 · see citing works

Mendelian Disorders of High-Density Lipoprotein Metabolism

Oldoni, F., Sinke, R. J., & Kuivenhoven, J. A. (2014) · Circulation Research · doi:10.1161/circresaha.113.300634 · Cited by 48 · see citing works

Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside

Mezentsev, A., Bezsonov, E. E., Kashirskikh, D. A., Baig, M. S., Eid, A. H., & Orekhov, A. N. (2021) · Biomedicines · doi:10.3390/biomedicines9060600 · Cited by 48 · see citing works

Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics

Salazar, J. J., Olivar, L. C., Ramos, E., Chávez-Castillo, M., Rojas, J., & Bermúdez, V. (2015) · Cholesterol · doi:10.1155/2015/296417 · Cited by 48 · see citing works

Comprehensive assessment of metabolic syndrome among rural Bangladeshi women

Jesmin, S., Islam, M. R., Islam, A. M. S., Mia, M. S., Sultana, S. N., Zaedi, S., Yamaguchi, N., Iwashima, Y., Hiroe, M., & Watanabe, T. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-49 · Cited by 42 · see citing works

Novel rare mutations and promoter haplotypes in ABCA1 contribute to low‐HDL‐C levels

Slatter, T., Jones, G. T., Williams, M., van Rij, A., & McCormick, S. P. A. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00940.x · Cited by 42 · see citing works

Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome

Rached, F. H., Santos, R. D., Camont, L., Miname, M. H., Lhomme, M., Dauteuille, C., Lecocq, S., Junior, C. V. S., Chapman, M. J., & Kontush, A. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m051631 · Cited by 41 · see citing works

Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders

Daniil, G., Phedonos, A., Holleboom, A. G., Motazacker, M. M., Argyri, L., Kuivenhoven, J. A., & Chroni, A. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.03.011 · Cited by 38 · see citing works

Lipidation of apolipoprotein A-I by ATP-binding cassette transporter (ABC) A1 generates an interaction partner for ABCG1 but not for scavenger receptor BI

Lorenzi, I., von Eckardstein, A., Radosavljevic, S., & Rohrer, L. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.04.006 · Cited by 37 · see citing works

Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency

Fasano, T., Zanoni, P., Rabacchi, C., Pisciotta, L., Favari, E., Adorni, M. P., Deegan, P. B., Park, A. J., Hlaing, T., Feher, M. D., et al. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.08.005 · Cited by 36 · see citing works

Guías de práctica clínica sobre prevención de la enfermedad cardiovascular: Versión resumida

Graham, I. D., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2008) · Revista Española de Cardiología · Cited by 34 · see citing works

[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Spanish adaptation of the CEIPC 2008].

Lobos, J. M., Royo‐Bordonada, M. Á., Brotons, C., Álvarez-Sala, L., Armario, P., Maiques, A., Mauricio, D., Sans, S., Villar, F., Lizcano‐Álvarez, A., et al. (2009) · PubMed · Cited by 33 · see citing works

Implications of torcetrapib failure for the future of HDL therapy: is HDL-cholesterol the right target?

von Eckardstein, A. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.6 · Cited by 30 · see citing works

A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large family

Maranghi, M., Truglio, G., Gallo, A., Grieco, E., Verrienti, A., Montali, A., Gallo, P., Alesini, F., Arca, M., & Lucarelli, M. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.064 · Cited by 27 · see citing works

Severe HDL deficiency due to novel defects in the ABCA1 transporter

Pisciotta, L., Bocchi, L., Candini, C., Sallo, R., Zanotti, I., Fasano, T., Chakrapani, A., Bates, T., Bonardi, R., Cantàfora, A., et al. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02019.x · Cited by 25 · see citing works

Interactions of six SNPs in APOA1 gene and types of obesity on low HDL-C disease in Xinjiang pastoral area of China

Wang, X., He, J., Guo, H., Mu, L., Hu, Y., Ma, J., Yan, Y., Ma, R., Li, S., Ding, Y., et al. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0581-8 · Cited by 25 · see citing works

Identification of four novel genes contributing to familial elevated plasma HDL cholesterol in humans

Singaraja, R. R., Tietjen, I., Hovingh, G. K., Franchini, P. L., Radomski, C., Wong, K. K., vanHeek, M., Stylianou, I. M., Lin, L., Wang, L., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m048710 · Cited by 24 · see citing works

Severe acquired (secondary) high-density lipoprotein deficiency

Goldberg, R. B., & Mendez, A. J. (2007) · Journal of clinical lipidology · doi:10.1016/j.jacl.2007.02.003 · Cited by 24 · see citing works

HDL Dysfunction Caused by Mutations in apoA-I and Other Genes that are Critical for HDL Biogenesis and Remodeling

Chroni, A., & Kardassis, D. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180313114950 · Cited by 22 · see citing works

Distinct phospholipid and sphingolipid species are linked to altered HDL function in apolipoprotein A-I deficiency

Zakiev, E., Rached, F. H., Lhomme, M., Darabi, M., Ponnaiah, M., Becker, P. H., Thérond, P., Junior, C. V. S., Santos, R. D., Chapman, M. J., et al. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.02.004 · Cited by 20 · see citing works

[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. CEIPC 2008 Spanish adaptation].

Lobos, J. M., Royo‐Bordonada, M. Á., Brotons, C., Álvarez-Sala, L., Armario, P., Maiques, A., Mauricio, D., Sans, S., Villar, F., Lizcano‐Álvarez, A., et al. (2009) · PubMed · Cited by 20 · see citing works

Guías de práctica clínica sobre prevención de la enfermedad cardiovascular. Versión corregida 22/07/2009

Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., Backer, G. D. D., Ebrahim, S., Gjelsvik, B., et al. (2008) · Revista Española de Cardiología · doi:10.1157/13114961 · Cited by 16 · see citing works

Genetic Polymorphisms in the APOA1 Gene and their Relationship with Serum HDL Cholesterol Levels

Bandarian, F., Hedayati, M., DANESHPOUR, M. S., Naseri, M., & Azizi, F. (2013) · Lipids · doi:10.1007/s11745-013-3847-6 · Cited by 19 · see citing works

Current Status of Familial LCAT Deficiency in Japan

Kuroda, M., Bujo, H., Yokote, K., Murano, T., Yamaguchi, T., Ogura, M., Ikewaki, K., Koseki, M., Takeuchi, Y., Nakatsuka, A., et al. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17051 · Cited by 19 · see citing works

Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: A case report and literature review

Ishibashi, R., Takemoto, M., Tsurutani, Y., Kuroda, M., Ogawa, M., Wakabayashi, H., Uesugi, N., Nagata, M., Imai, N., Hattori, A., et al. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.05.002 · Cited by 18 · see citing works

High density lipoprotein: When to rethink too much of a good thing

Dastmalchi, L. N., German, C. A., & Taub, P. R. (2023) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2023.100511 · Cited by 18 · see citing works

Multiple abnormally spliced ABCA1 mRNAs caused by a novel splice site mutation of ABCA1 gene in a patient with Tangier disease

Bocchi, L., Pisciotta, L., Fasano, T., Candini, C., Puntoni, M. R., Sampietro, T., Bertolini, S., & Calandra, S. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.01.008 · Cited by 17 · see citing works

Primary genetic disorders affecting high density lipoprotein (HDL)

Kosmas, C. E., Silverio, D., Sourlas, A., Garcia, F., Montan, P. D., & Guzman, E. (2018) · Drugs in Context · doi:10.7573/dic.212546 · Cited by 17 · see citing works

Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Adaptación española del CEIPC 2008

Lobos, J. M., Royo‐Bordonada, M. Á., Brotons, C., Sala, L. A., Armario, P., Maiques, A., Mauricio, D., Sans, S., Villar, F., Lizcano, A. P. R., et al. (2009) · Revista Clínica Española · doi:10.1016/s0014-2565(09)71477-8 · Cited by 16 · see citing works

A decreased level of high‐density lipoprotein is a possible risk factor for type 2 diabetes mellitus: A review

Bodaghi, A. B., Ebadi, E., Gholami, M. J., Azizi, R., & Shariati, A. (2023) · Health Science Reports · doi:10.1002/hsr2.1779 · Cited by 15 · see citing works

Rare thesaurismosis and xanthomatosis

Chalès, G., Coiffier, G., & Guggenbuhl, P. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.10.016 · Cited by 15 · see citing works

Familial occurrence of abnormalities of high-density lipoprotein cholesterol

Kral, B. G., & Becker, D. M. (2007) · Journal of clinical lipidology · doi:10.1016/j.jacl.2007.01.006 · Cited by 13 · see citing works

Marked high density lipoprotein deficiency due to apolipoprotein A-I Tomioka (codon 138 deletion)

Wada, M., Iso, T., Asztalos, B. F., Takama, N., Nakajima, T., Seta, Y., Kaneko, K., Taniguchi, Y., Kobayashi, H., Nakajima, K., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.018 · Cited by 13 · see citing works

Lipoprotein distribution and serum concentrations of 7α-hydroxy-4-cholesten-3-one and bile acids: effects of monogenic disturbances in high-density lipoprotein metabolism

Steiner, C., Holleboom, A. G., Karuna, R., Motazacker, M. M., Kuivenhoven, J. A., Frikke‐Schmidt, R., Tybjærg‐Hansen, A., Rohrer, L., Rentsch, K., & von Eckardstein, A. (2011) · Clinical Science · doi:10.1042/cs20110482 · Cited by 12 · see citing works

Molecular characterization of two patients with severe LCAT deficiency

Charlton-Menys, V., Pisciotta, L., Durrington, P. N., Neary, R. H., Short, C. D., Calabresi, L., Calandra, S., & Bertolini, S. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm311 · Cited by 12 · see citing works

Genetics and regulation of HDL metabolism

Kardassis, D., Thymiakou, E., & Chroni, A. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159060 · Cited by 12 · see citing works

Identification of the first Tangier disease patient in Lebanon carrying a new pathogenic variant in ABCA1

Khoury, P. E., Couvert, P., Elbitar, S., Ghaleb, Y., Khalil, Y. A., Azar, Y., Ayoub, C., Superville, A., Guérin, M., Rabès, J., et al. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.08.013 · Cited by 11 · see citing works

Criterios de derivación para pacientes a las unidades de lípidos de la Sociedad Española de Arteriosclerosis

Sánchez-Chaparro, M. Á., Pérez‐Martínez, P., Ibarretxe, D., Tembra, M. S., & Valdivielso, P. (2018) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2018.04.005 · Cited by 11 · see citing works

Management of Inherited Atherogenic Dyslipidemias in Children

Guardamagna, O., Cagliero, P., & Abello, F. (2012) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2012.01146.x · Cited by 10 · see citing works

Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Adaptación española del CEIPC 2008

Lobos, J. M., Royo‐Bordonada, M. Á., Brotons, C., Álvarez-Sala, L., Armario, P., Maiques, A., Mauricio, D., Sans, S., Villar, F., Lizcano‐Álvarez, A., et al. (2009) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(09)72176-2 · Cited by 10 · see citing works

Very low HDL levels: clinical assessment and management

Bonilha, I., Luchiari, B., Nadruz, W., & Sposito, A. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000585 · Cited by 12 · see citing works

[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. CEIPC 2008 Spanish Adaptation].

Bejarano, J. M. L., Royo-Bordonada, M., Brotons, C., Álvarez-Sala, L., Armario, P., Maiques, A., Mauricio, D., Sans, S., Villar, F., Lizcano, Á., et al. (2009) · Atención Primaria · doi:10.1016/j.aprim.2008.10.024 · Cited by 54 · see citing works

Profiles of inflammatory markers and lipoprotein subclasses in patients undergoing continuous ambulatory peritoneal dialysis

Kon, M., Hirayama, S., Horiuchi, Y., Ueno, T., Idei, M., Fueki, Y., Seino, U., Goto, S., Maruyama, H., Iino, N., et al. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.016 · Cited by 10 · see citing works

A new APOA1 mutation with severe HDL-cholesterol deficiency and premature coronary artery disease

Esperón, P., Vital, M., Raggio, V. E., Alallón, W., & Stoll, M. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.10.015 · Cited by 10 · see citing works

Criteria for referring patients to Spanish Atherosclerosis Society lipid units

Sánchez-Chaparro, M. Á., Pérez‐Martínez, P., Ibarretxe, D., Tembra, M. S., Valdivielso, P., Ros, E., Martínez, S. H., Cenarro, A., Sánchez, M. Á., Ibarretxe, D., et al. (2019) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2019.01.002 · Cited by 9 · see citing works

Familial genetic risk factors in premature cardiovascular disease: a family study

Yücel, O., Karahan, O., Zorlu, A., & Manduz, Ş. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1430-x · Cited by 9 · see citing works

Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Adaptación española del CEIPC 2008

Lobos, J. M., Royo‐Bordonada, M. Á., Brotons, C., Álvarez-Sala, L., Armario, P., Maiques, A., Mauricio, D., Sans, S., Villar, F., Lizcano‐Álvarez, A., et al. (2009) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(09)71131-3 · Cited by 9 · see citing works

Apolipoprotein A1 in Cerebrospinal Fluid Is Insufficient to Distinguish Alzheimer’s Disease from Other Dementias in a Naturalistic, Clinical Setting

Stoye, N. M., Jung, P., Guilherme, M. D. S., Lotz, J., Fellgiebel, A., & Endres, K. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-190165 · Cited by 8 · see citing works

Guía Europea de Prevención Cardiovascular en la Práctica Clínica: Adaptación Española del CEIPC 2008

Lobos, J. M., Royo‐Bordonada, M. Á., Brotons, C., Álvarez-Sala, L., Armario, P., Maiques, A., Mauricio, D., Sans, S., Álvarez, F. V., Lizcaino, A., et al. (2008) · doi:10.4321/repisalud.5189 · Cited by 8 · see citing works

A complex phenotype in a child with familial HDL deficiency due to a novel frameshift mutation in APOA1 gene (apoA-I Guastalla )

Pisciotta, L., Vitali, C., Favari, E., Fossa, P., Adorni, M. P., Leone, D., Artom, N., Fresa, R., Calabresi, L., Calandra, S., et al. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.09.001 · Cited by 7 · see citing works

In vivo triglyceride synthesis in subcutaneous adipose tissue of humans correlates with plasma HDL parameters

Tuvdendorj, D., Munoz, A., Ruiz-Barros, V., Schwarz, J., Montalto, G., Chandalia, M., Sowers, L. C., Rizzo, M., Murphy, E. J., & Abate, N. I. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.06.024 · Cited by 6 · see citing works

Lipoprotein and Lipid Metabolism

Hegele, R. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00100-2 · Cited by 7 · see citing works

Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Adaptación española del CEIPC 2008

Lobos, J. M., Royo‐Bordonada, M. Á., Brotons, C., Álvarez-Sala, L., Armario, P., Maiques, A., Mauricio, D., Sans, S., Villar, F., Lizcano‐Álvarez, A., et al. (2009) · Medicina de Familia SEMERGEN · doi:10.1016/s1138-3593(09)70424-1 · Cited by 5 · see citing works

Lipoprotein and Lipid Metabolism

Hegele, R. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-812535-9.00007-8 · Cited by 5 · see citing works

High-Density Lipoproteins

Toth, P. P. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-533-6_9 · Cited by 5 · see citing works

HDL – a difficult friend

von Eckardstein, A. (2008) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2008.10.004 · Cited by 5 · see citing works

[The role of molecular biology in the diagnosis and treatment of cardiovascular diseases].

Mariotti, S., Capparuccia, C., Ripa, C., Olivieri, F., Lisa, R., Procopio, A. D., & Antonicelli, R. (2010) · PubMed · Cited by 4 · see citing works

Cornea and Sclera

Yanoff, M., & Sassani, J. W. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2874-9.00008-9 · Cited by 4 · see citing works

Bases genéticas de la variación en los niveles plasmáticos de HDL-colesterol

Molina, M. T. V. (2008) · Revista de Endocrinología y Nutrición · Cited by 4 · see citing works

Homozygous Tangier disease with undetectable serum high density lipoprotein cholesterol levels and no clinical features

Gell, J. S., & van Heyningen, C. (2013) · Cited by 3 · see citing works

High-Density Lipoproteins

Darabi, M., Zakiev, E., & Kontush, A. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56514-5_18 · Cited by 3 · see citing works

Corneal thickness in the case of familial lecithin-cholesterol acyltransferase deficiency

Kinoshita, S., Sugita, S., & Yoshida, A. (2021) · American Journal of Ophthalmology Case Reports · doi:10.1016/j.ajoc.2021.101211 · Cited by 2 · see citing works

Genetics of lipoprotein disorders and coronary atheroma

Durrington, P. N. (2007) · CRC Press eBooks · doi:10.1201/b13464-13 · Cited by 2 · see citing works

Hypertriglyzeridämie und HDL-Mangel

von Eckardstein, A. (2017) · Praxis · doi:10.1024/1661-8157/a002760 · Cited by 1 · see citing works

Lipoprotein Disorders

Kathiresan, S., & Rader, D. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374934-5.00023-4 · Cited by 1 · see citing works

Genetic Disorders of Lipoprotein Metabolism: Diagnosis and Management

Cupido, A. J., Stoekenbroek, R. M., & Kastelein, J. J. P. (2016) · Springer eBooks · doi:10.1007/978-3-319-44203-7_21 · Cited by 1 · see citing works

A novel homozygous frameshift mutation in the APOA1 gene associated with marked high-density lipoprotein deficiency

Takeda, T., Ide, T., Okuda, D., Kuroda, M., Asada, S., Kirinashizawa, M., Yamamoto, M., Miyoshi, J., Yokote, K., & Mizutani, N. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2022.06.001 · Cited by 1 · see citing works

Agent-based modeling predicts HDL-independent pathway of removal of excess surface lipids from very low density lipoprotein

Paalvast, Y., Kuivenhoven, J. A., Bakker, B. M., & Groen, A. K. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.052 · Cited by 1 · see citing works

Genetic Disorders of Lipoprotein Metabolism

Cuchel, M., Qasim, A., & Rader, D. J. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-533-6_2 · Cited by 1 · see citing works

Genetics of Coronary Heart Disease

Cunnington, M. S., & Keavney, B. D. (2009) · doi:10.1002/9781444309768.ch21 · Cited by 1 · see citing works

Genetic Disorders of the Lipoprotein Metabolism; Diagnosis and Management

Bakker, A. C., Jakulj, L., & Kastelein, J. J. P. (2010) · Springer eBooks · doi:10.1007/978-1-84996-471-5_20 · Cited by 1 · see citing works

Klinische Befunde und rationelle Differenzialdiagnostik der diabetischen Dyslipidämie

von Eckardstein, A. (2012) · Der Diabetologe · doi:10.1007/s11428-012-0890-5

HDL and Metabolic Syndrome

Cavelier, C., & von Eckardstein, A. (2007) · doi:10.1002/9783527625178.ch18

Inherited Lipoprotein Disorders

Dembowski, E., & Davidson, M. H. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-502-6_4

HDL – „Game over“?

Klose, G., & Hambrecht, R. (2013) · Der Kardiologe · doi:10.1007/s12181-013-0505-4

2 Premature atherosclerose

Hutten, B. A., Sivapalaratnam, S., & Trip, M. D. (2010) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-9572-9_2

New Research Advances in Genetics Associated With High-density Lipoprotein Cholesterol*

Xiao-Yan, L. I. U., Lü, Q., Chen, W., & Tang, C. (2013) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2012.00140

Hypolipodemias in children

Erdur, C. B., & Güzin, Y. (2016) · Journal of Dr Behcet Uz Children s Hospital · doi:10.5222/buchd.2016.001

From the NLA President: Making the right connections

Bittner, V. (2010)

Fettstoffwechsel: Diagnostik, Bewertung und Behandlung primärer Dyslipoproteinämien

März, W., & Klose, G. (2017) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/s-0037-1618961

Hypertriglyzeridämie und HDL-Mangel

von Eckardstein, A. (2017) · CardioVasc · doi:10.1007/s15027-017-1275-x

Lipoprotein Disorders

Kathiresan, S., & Rader, D. J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369420-1.00055-x

Epidemiology

Kontush, A., & Chapman, M. J. (2011) · Wiley eBooks · doi:10.1002/9781118158678.ch5

Angeborene Störungen des High-density-Lipoprotein-Stoffwechsels

von Eckardstein, A. (2019) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-181689

Diagnosis and treatment of high density lipoprotein deficiency

Schaefer, E. J., Anthanont, P., Diffenderfer, M. R., Polisecki, E. Y., & Asztalos, B. F. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2016.08.006 · Cited by 88 · see citing works

Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency.

Schaefer, E. J. (1984) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.4.4.303 · Cited by 174 · see citing works

Genetic Etiology of Isolated Low HDL Syndrome

Kiss, R. S., Kavaslar, N., Okuhira, K., Freeman, M. W., Wälter, S., Milne, R. W., McPherson, R., & Marcel, Y. L. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.106.137646 · Cited by 58 · see citing works

Clinical presentation, laboratory values, and coronary heart disease risk in marked high-density lipoprotein-deficiency states.

Santos, R. D., Asztalos, B., Martinez, L., Miname, M., Polisecki, E., & Schaefer, E. (2008) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2008.06.002 · Cited by 40 · see citing works